ReShape Lifesciences Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
HIND$1.59+0.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
There have been no material changes to the risk factors set forth in Item 1A.“Risk Factors” of our 2023 Annual Report on Form 10-K filed on April 1, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.